XML 13 R2.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 153,192 $ 180,002
Short term investments 94,809 110,704
Prepaid expenses and other current assets 15,249 12,922
Total current assets 263,250 303,628
Property and equipment, net 19,066 17,938
Operating lease assets 26,246 18,208
Restricted cash 8,185 8,000
Restricted investments 1,401 1,401
Long term investments 0 495
Other non-current assets 1,741 5,189
Total assets 319,889 354,859
Current liabilities:    
Accounts payable 6,791 13,735
Accrued expenses and other current liabilities [1] 48,278 45,094
Operating lease liabilities 6,849 6,610
Deferred revenue - related party 20,441 16,819
Total current liabilities 82,359 82,258
Long term portion of note payable, net of discount 50,437 24,643
Operating lease liabilities, net of current portion 20,346 17,958
Deferred revenue, net of current portion - related party 81,883 86,998
Other long-term liabilities [2] 3,908 11,495
Total liabilities 238,933 223,352
Commitments and contingencies (Note 11)
Stockholders' equity:    
Preferred stock, $0.001 par value; 10,000,000 shares authorized at March 31, 2022 and December 31, 2021; no shares issued and outstanding at March 31, 2022 and December 31, 2021 0 0
Common stock, $0.001 par value; 200,000,000 shares authorized at March 31, 2022 and December 31, 2021; 91,841,974 and 91,459,239 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively 92 92
Additional paid-in capital 752,057 745,829
Accumulated other comprehensive income (loss) (215) (60)
Accumulated deficit (670,978) (614,354)
Total stockholders’ equity 80,956 131,507
Total liabilities and stockholders’ equity $ 319,889 $ 354,859
[1] Includes related party amounts of $29,809 and $21,098 at March 31, 2022 and December 31, 2021, respectively (see Note 11)
[2] Includes related party amounts of $2,981 and $10,585 at March 31, 2022 and December 31, 2021, respectively (see Note 11)